Apoptosis dysregulation is a significant factor in cancer pathogenesis and may result from the overexpression of antiapoptotic proteins such as inhibitor of apoptosis proteins (IAPs). Among these IAPs, the most potent and wellcharacterized anti-apoptotic member is X-linked inhibitor of apoptosis protein (XIAP), which directly inhibits caspase-9 via its BIR3 domain and caspase-3 and -7 via its BIR2 domain. Current chemotherapeutic agents that target XIAP are frequently associated with toxicity and unfavorable side effects. Here, a virtual screening approach was utilized to screen a total of 2,777 phytochemicals from the ZINC database in order to find putative XIAP inhibitors. The top hit compounds, ZINC1725698, ZINC4104879, ZINC257053067, and ZINC6585367 were chosen for their high binding affinity and specificity for the XIAP binding pocket. Notably, as compared to the control drug (Hydroxythio Acetildenafil), these hit compounds exhibited a greater affinity for the XIAP binding site. Furthermore, these compounds were found to possess the drug-like properties, making them viable candidates for future experimental validation as possible anticancer agents.